Key result
Maternal blood pressure during pregnancy shows no causal link to adverse offspring cardiometabolic outcomes.
Why the study?
It is unclear whether the association between higher maternal blood pressure during pregnancy and increased offspring cardiometabolic risk is causal through intrauterine mechanisms.
Does maternal blood pressure during pregnancy causally increase the risk of adverse cardiometabolic outcomes in offspring?
Observational (n=51,131)
Yes
Does maternal blood pressure during pregnancy causally increase the risk of adverse cardiometabolic outcomes in offspring?
Mendelian randomization provides little evidence that maternal blood pressure during pregnancy is a major causal risk factor for adverse offspring cardiometabolic outcomes, challenging previous observational associations.
Little evidence supports causal effects of maternal BP on offspring cardiometabolic outcomes; leaves open confounding in prior observational reports.
Observational epidemiological studies have reported that higher maternal blood pressure (BP) during pregnancy is associated with increased future risk of offspring cardiometabolic disease. However, it is unclear whether this association represents a causal relationship through intrauterine mechanisms. We used a Mendelian randomization (MR) framework to examine the relationship between unweighted maternal genetic scores for systolic BP and diastolic BP and a range of cardiometabolic risk factors in the offspring of up to 29 708 genotyped mother-offspring pairs from the UKB study (UK Biobank) and the HUNT study (Trøndelag Health). We conducted similar analyses in up to 21 423 father-offspring pairs from the same cohorts. We confirmed that the BP-associated genetic variants from the general population sample also had similar effects on maternal BP during pregnancy in independent cohorts. We did not detect any association between maternal (or paternal) unweighted genetic scores and cardiometabolic offspring outcomes in the meta-analysis of UKB and HUNT after adjusting for offspring genotypes at the same loci. We find little evidence to support the notion that maternal BP is a major causal risk factor for adverse offspring cardiometabolic outcomes in later life.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted an observational in Maternal blood pressure during pregnancy and offspring cardiometabolic health (n=51,131). Maternal blood pressure during pregnancy (genetic scores for systolic and diastolic BP) vs. Paternal genetic scores was evaluated on Cardiometabolic offspring outcomes. Maternal blood pressure during pregnancy, assessed via genetic scores, showed no causal association with adverse offspring cardiometabolic outcomes in later life.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: